SIG Group AG

SIG reported H1 2026 revenue of EUR 1.56 billion. Revenue increased 0.8% at constant currency, and 0.4% excluding the resin pass-through effect in bag-in-box. Adjusted EBIT was EUR 244 million, up EUR 11 million year over year, with adjusted EBIT margin at 15.6% (+80 bps). Adjusted net income was EUR 133 million, broadly stable, and free cash flow improved by more than EUR 100 million to negative EUR 32 million. In Q2, revenue grew 1.5% at constant currency, adjusted EBIT margin reached 17.5%, and free cash flow was positive EUR 32 million versus negative EUR 50 million a year ago. For the full year 2026, SIG confirmed guidance for revenue growth of 0% to 2%, adjusted EBIT margin of 15.7% to 16.2%, net capex including leases of 6% to 8% of revenue, and an adjusted effective tax rate of 26% to 28%.

Mikko Keto framed the first half as a proof point for SIG’s resilience in a volatile environment, citing Middle East uncertainty, higher raw materials and freight, and softness in some end markets. He emphasized that surcharge mechanisms and improvement measures are helping offset cost inflation, while the business remains focused on cost discipline, operational excellence, and accelerating growth in aseptic system solutions. His tone was constructive but cautious, repeatedly noting that geopolitics still create risk in the second half.

Ann-Kristin Erkens highlighted adjusted EBIT of EUR 244 million, an 80 bps margin improvement to 15.6%, and free cash flow of negative EUR 32 million in H1, including positive Q2 free cash flow of EUR 32 million. She said the margin bridge reflected timely surcharges, a EUR 5 million positive sourcing contribution in Q1 that turned negative in Q2, strong production efficiencies and SG&A savings, and lower depreciation from prior-year impairments. She also noted net capex including leases fell to EUR 96 million, gross debt declined by almost EUR 240 million and net debt by almost EUR 290 million versus June last year, and covenant leverage improved to 2.8x from 3.0x.

Analysts focused on second-half volume trends, European juice weakness, the pace and durability of surcharge benefits, competitive pressure in China, and whether Americas growth was unusually strong. Management said aseptic carton volumes look mildly positive excluding some one-offs and should improve sequentially, while Europe’s juice softness may take time to bottom out and bag-in-box/spouted pouch likely needs until 2027 for a more sustainable turnaround. On China and Southeast Asia, they said SIG remains competitively strong, but pricing is harder in a low-inflation environment; on surcharges, they said Q2 benefits were low single-digit percentage contributions and should not be expected to ramp materially further.